Comparison of Tolerance of Combination Carboplatin and Paclitaxel Chemotherapy by Age in Women with Ovarian Cancer

By Villella J.A.   Chaudhry T.   Pearl M.L.   Valea F.   DiSilvestro P.A.   Pollack S.   Chalas E.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 316-322

Academic Press

Access to resources Recommend Favorite

Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer

By Havrilesky L.J.   Alvarez A.A.   Sayer R.A.   Lancaster J.M.   Soper J.T.   Berchuck A.   Clarke-Pearson D.L.   Rodriguez G.C.   Carney M.E.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 51-57

Academic Press

Access to resources Recommend Favorite

Three-Hour Paclitaxel Infusion and Carboplatin Is an Effective Outpatient Treatment for Stage III Epithelial Ovarian Cancer

By Brown J.V.   Rettenmaier M.A.   Dillman R.A.   Birk C.L.   Culkin K.   Micha J.P.  

Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. : 166-168

Elsevier

Access to resources Recommend Favorite

Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer

By Hofstra L.S.   Bos A.M.E.   de Vries E.G.E.   van der Zee A.G.J.   Willemsen A.T.M.   Rosing H.   Beijnen J.H.   Mulder N.H.   Aalders J.G.   Willemse P.H.B.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 517-523

Academic Press

Access to resources Recommend Favorite

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

By Romanini A.   Tanganelli L.   Carnino F.   Fanucchi A.   Lionetto R.   Pastorino S.   Cosio S.   Gadducci A.   Conte P.F.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 354-359

Elsevier

Access to resources Recommend Favorite